Literature DB >> 34760476

Heart assist devices and their impact on arterial Doppler: When the waveform appears flat or serrated.

Yi Wang1,2.   

Abstract

OBJECTIVE: The purpose of this article was to review the principal mechanisms of three types of heart assist devices, to explore their haemodynamic impacts on spectral Doppler and to discuss the associated challenges in diagnostic ultrasound.
CONCLUSION: Heart assist devices are used in patients with advanced heart failure as bridge to transplantation or destination therapy. The arterial Doppler waveform features can be altered after the implantation of the devices. A continuous-flow device converts the arterial waveform into a venous-like waveform with a mean velocity that can be used in stenosis evaluation. When the pulsatile device produces extra pulses between the natural heartbeats, together they produce serrated arterial waveforms. When the pulsatile device serves as the only pumping source, the arterial waveforms are similar to the natural ones. Colour Doppler features are maintained despite all the spectral Doppler changes. These devices can affect both ultrasound scanning and interpretation. Therefore, it is essential to understand the principal mechanisms of these devices and their haemodynamic impacts so that an accurate ultrasound diagnosis can be made.
© 2017 Australasian Society for Ultrasound in Medicine.

Entities:  

Keywords:  C‐Pulse® heart assist system; heart assist device; spectral Doppler; total artificial heart; ventricular assist devices

Year:  2017        PMID: 34760476      PMCID: PMC8409882          DOI: 10.1002/ajum.12049

Source DB:  PubMed          Journal:  Australas J Ultrasound Med        ISSN: 1836-6864


  6 in total

1.  Results with SynCardia total artificial heart beyond 1 year.

Authors:  Gianluca Torregrossa; Michiel Morshuis; Robin Varghese; Leila Hosseinian; Vladimiro Vida; Vincenzo Tarzia; Antonio Loforte; Daniel Duveau; Francisco Arabia; Pascal Leprince; Vigneshwa Kasirajan; Friedhelm Beyersdorf; Francesco Musumeci; Roland Hetzer; Thoamas Krabatsch; Jan Gummert; Jack Copeland; Gino Gerosa
Journal:  ASAIO J       Date:  2014 Nov-Dec       Impact factor: 2.872

2.  Outcomes in advanced heart failure patients with left ventricular assist devices for destination therapy.

Authors:  Soon J Park; Carmelo A Milano; Antone J Tatooles; Joseph G Rogers; Robert M Adamson; D Eric Steidley; Gregory A Ewald; Kartik S Sundareswaran; David J Farrar; Mark S Slaughter
Journal:  Circ Heart Fail       Date:  2012-01-26       Impact factor: 8.790

3.  Chronic extra-aortic balloon counterpulsation: first-in-human pilot study in end-stage heart failure.

Authors:  Christopher S Hayward; William S Peters; Alan F Merry; Peter N Ruygrok; Paul Jansz; Gerry O'Driscoll; Robert I Larbalestier; Julian A Smith; Betty Ho; Malcolm E Legget; F Paget Milsom
Journal:  J Heart Lung Transplant       Date:  2010-12       Impact factor: 10.247

4.  Clinical management of continuous-flow left ventricular assist devices in advanced heart failure.

Authors:  Mark S Slaughter; Francis D Pagani; Joseph G Rogers; Leslie W Miller; Benjamin Sun; Stuart D Russell; Randall C Starling; Leway Chen; Andrew J Boyle; Suzanne Chillcott; Robert M Adamson; Margaret S Blood; Margarita T Camacho; Katherine A Idrissi; Michael Petty; Michael Sobieski; Susan Wright; Timothy J Myers; David J Farrar
Journal:  J Heart Lung Transplant       Date:  2010-02-24       Impact factor: 10.247

Review 5.  SynCardia: the total artificial heart.

Authors:  Gianluca Torregrossa; Anelechi Anyanwu; Fabio Zucchetta; Gino Gerosa
Journal:  Ann Cardiothorac Surg       Date:  2014-11

Review 6.  The future is here: ventricular assist devices for the failing heart.

Authors:  Ana C Alba; Diego H Delgado
Journal:  Expert Rev Cardiovasc Ther       Date:  2009-09
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.